Ziprasidone Hcl
Brand name: Ziprasidone Hcl
Rank #420 of 500 drugs by total cost
$20.8M
Total Cost
239,041
Total Claims
$20.8M
Total Cost
8,071
Prescribers
$87
Cost per Claim
6,138
Beneficiaries
289,214
30-Day Fills
$2,578
Avg Cost/Provider
30
Avg Claims/Provider
About Ziprasidone Hcl
Ziprasidone Hcl (sold as Ziprasidone Hcl) was prescribed 239,041 times by 8,071 Medicare Part D providers in 2023, costing the program $20.8M. At $87 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 417 | Methenamine Hippurate (Methenamine Hippurate) | $21.0M | 246,988 |
| 418 | Daratumumab-Hyaluronidase-Fihj (Darzalex Faspro) | $21.0M | 1,444 |
| 419 | Insulin Pump Cart,cont Inf,bt (Omnipod Dash Pods (Gen 4)) | $20.9M | 16,219 |
| 420 | Ziprasidone Hcl (Ziprasidone Hcl) | $20.8M | 239,041 |
| 421 | Sodium, Potassium,mag Sulfates (Sod Sulf-Potass Sulf-Mag Sulf) | $20.7M | 246,742 |
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology